immuno oncology frontiers world miami


Steven Peskin

Steven Peskin

Executive Medical Director, Population Health, Horizon Blue Cross Blue Shield of New Jersey

Dr. Steven R. Peskin is the Executive Medical Director Population Management at Horizon Blue Cross Blue Shield of New Jersey. His expertise encompasses physician leadership, medical delivery management, performance improvement in health care, contracting; applications in technology include mobile/social media, clinical/scientific communications for health care professional and consumer audiences.

Dr. Peskin is the former Executive Vice President and Chief Medical Officer for MediMedia USA, CEO of Pharmaceutical Research Plus, President/COO of Nelson Managed Solutions and has worked in multiple executive positions in health plans at PacifiCare Health Systems, CIGNA Healthcare, and John Hancock. Dr. Peskin has authored industry and scientific articles, book chapters and spoken at various conferences and events about physician leadership, the medical home, mobile health and social media.

Dr. Peskin continues to work at the Rutgers Robert Wood Johnson School of Medicine as a clinical preceptor and instructor at the Eric B. Chandler Clinic and assists in the business of medicine curriculum. He is Course Director for Internal Medicine Grand Rounds at The University Medical Center in Princeton. He has held faculty appointments in medicine at several universities across the country and is currently an Associate Clinical Professor of Medicine Rutgers Robert Wood Johnson School of Medicine.

Dr. Peskin is a Diplomat of the American Board of Internal Medicine and a Fellow of the American College of Physicians, serves as Governor for the Southern Region of the ACP in New Jersey, Board of Trustees for Friends of the National Library of Medicine, editorial advisory boards of The Journal of Population Health Management and Managed Care and is a Senior Scholar in the School of Population Health at Thomas Jefferson University. His community service includes the Boards of the Greater Donnelley Neighborhood Initiative and Young Audiences of New Jersey.

Dr. Peskin received a bachelor’s degree from The University of North Carolina Chapel Hill and a medical degree from Emory University School of Medicine. He completed residency at Saint Elizabeth’s Medical Center in Boston and holds an MBA from the Sloan School of Management at Massachusetts Institute of Technology.

  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy